Literature DB >> 19357171

Canine distemper virus selectively inhibits apoptosis progression in infected immune cells.

Stéphane Pillet1, Veronika von Messling.   

Abstract

Morbillivirus infections are characterized by severe leukopenia and immune suppression that develop even before the onset of clinical signs. To characterize in more detail the fate of the immune cells during the critical first week, we evaluated the overall viability, level of apoptosis, cell cycle status, and extent of infection in different immune tissues of ferrets inoculated with a lethal canine distemper virus (CDV) strain. Initial experiments with MDCK cells, a canine epithelial cell line, revealed that CDV infection resulted in only a marginal increase in apoptosis at high infection levels and that infected cells were more resistant to chemically induced apoptosis. In ferrets, levels of viability and early and late apoptosis remained stable in thymus and lymph node, where more than 80% of cells were infected, whereas a gradual albeit small increase in apoptosis was observed in peripheral blood mononuclear cells and spleen. Furthermore, the progression of spontaneous apoptosis in infected cells was inhibited, while the proportion of apoptotic noninfected "bystander" cells increased. The distribution of cells in the different stages of the cell cycle in the bone marrow was not affected, but dividing cells in the thymus decreased by 50%, and a 10-fold increase in cell division was noted in the spleen. It is unlikely that the extent of infection-induced cell death and cell cycle alterations alone can account for the dramatic leukopenia observed in this model. The investigation of additional mechanisms is therefore warranted.

Entities:  

Mesh:

Year:  2009        PMID: 19357171      PMCID: PMC2687397          DOI: 10.1128/JVI.00050-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Function of small hydrophobic proteins of paramyxovirus.

Authors:  Rebecca L Wilson; Sandra M Fuentes; Ping Wang; Erica C Taddeo; Alicia Klatt; Andrew J Henderson; Biao He
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  Receptor (SLAM [CD150]) recognition and the V protein sustain swift lymphocyte-based invasion of mucosal tissue and lymphatic organs by a morbillivirus.

Authors:  Veronika von Messling; Nicholas Svitek; Roberto Cattaneo
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  Measles virus-induced immunosuppression in vitro is associated with deregulation of G1 cell cycle control proteins.

Authors:  O Engelking; L M Fedorov; R Lilischkis; V Ter Meulen; S Schneider-Schaulies
Journal:  J Gen Virol       Date:  1999-07       Impact factor: 3.891

4.  Cell cycle arrest rather than apoptosis is associated with measles virus contact-mediated immunosuppression in vitro.

Authors:  J J Schnorr; M Seufert; J Schlender; J Borst; I C Johnston; V ter Meulen; S Schneider-Schaulies
Journal:  J Gen Virol       Date:  1997-12       Impact factor: 3.891

5.  Measles virus V protein inhibits p53 family member p73.

Authors:  Cristian D Cruz; Heidi Palosaari; Jean-Patrick Parisien; Patricia Devaux; Roberto Cattaneo; Toru Ouchi; Curt M Horvath
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Canine distemper virus induces apoptosis through caspase-3 and -8 activation in vero cells.

Authors:  M Kajita; H Katayama; T Murata; C Kai; M Hori; H Ozaki
Journal:  J Vet Med B Infect Dis Vet Public Health       Date:  2006-08

7.  Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains.

Authors:  P G Auwaerter; P A Rota; W R Elkins; R J Adams; T DeLozier; Y Shi; W J Bellini; B R Murphy; D E Griffin
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

8.  Measles virus nucleoprotein induces cell-proliferation arrest and apoptosis through NTAIL-NR and NCORE-FcgammaRIIB1 interactions, respectively.

Authors:  D Laine; J M Bourhis; S Longhi; M Flacher; L Cassard; B Canard; C Sautès-Fridman; C Rabourdin-Combe; H Valentin
Journal:  J Gen Virol       Date:  2005-06       Impact factor: 3.891

Review 9.  Morbillivirus infections, with special emphasis on morbilliviruses of carnivores.

Authors:  T Barrett
Journal:  Vet Microbiol       Date:  1999-09-01       Impact factor: 3.293

10.  Canine distemper virus-induced depletion of uninfected lymphocytes is associated with apoptosis.

Authors:  Martina Schobesberger; Artur Summerfield; Marcus G Doherr; Andreas Zurbriggen; Christian Griot
Journal:  Vet Immunol Immunopathol       Date:  2005-03-10       Impact factor: 2.046

View more
  5 in total

1.  Canine Distemper Virus Spread and Transmission to Naive Ferrets: Selective Pressure on Signaling Lymphocyte Activation Molecule-Dependent Entry.

Authors:  Bevan Sawatsky; Roberto Cattaneo; Veronika von Messling
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

Review 2.  Morbillivirus Experimental Animal Models: Measles Virus Pathogenesis Insights from Canine Distemper Virus.

Authors:  Renata da Fontoura Budaszewski; Veronika von Messling
Journal:  Viruses       Date:  2016-10-11       Impact factor: 5.048

Review 3.  Ferret models of viral pathogenesis.

Authors:  T Enkirch; V von Messling
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

4.  Phenotypic and Transcriptional Changes of Pulmonary Immune Responses in Dogs Following Canine Distemper Virus Infection.

Authors:  Elisa Chludzinski; Johanna Klemens; Małgorzata Ciurkiewicz; Robert Geffers; Pauline Pöpperl; Melanie Stoff; Dai-Lun Shin; Georg Herrler; Andreas Beineke
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

5.  Bta-miR-98 Suppresses Replication of Caprine Parainfluenza Virus Type 3 Through Inhibiting Apoptosis by Targeting Caspase-3.

Authors:  Jizong Li; Chunyan Zhong; Zheng Liao; Li Mao; Wenliang Li; Min Sun; Maojun Liu; Xinqin Ji; Chuanmin Liu; Tao Xue; Leilei Yang; Wenwen Zhang
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.